Intervention
Pramlintide acetate
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 7 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
7 shownEffect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes MellitusNCT02500979 · 2015-08-17
COMPLETEDEffect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DMNCT01708044 · 2012-11-01
COMPLETEDEffects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DMNCT00732147 · 2009-04-01
WITHDRAWNEvaluation of an Orally Administered Medication When Taken in Conjunction With PramlintideNCT00044707 · 2002-08-01
COMPLETEDEvaluation of the Effect of Pramlintide on Satiety and Food IntakeNCT00042601 · 2002-07-01
COMPLETEDEvaluation of the Bioavailability of PramlintideNCT00042471 · 2002-06-01
COMPLETEDEvaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose ControlNCT00042458 · 2002-04-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED6
WITHDRAWN1
Phase mix
PHASE23
PHASE12
NA1
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.